Phase II trial of ifosfamide and mesna in previously treated patients with non-hodgkin's lymphoma: Cancer and leukemia group b study 8552-Reference-Cited by-同舟云学术

Phase II trial of ifosfamide and mesna in previously treated patients with non-hodgkin's lymphoma: Cancer and leukemia group b study 8552

Published:2006-07 Issue:4-5 Volume:9 Page:189-196
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Case Delvyn C.,Anderson James,Ervin Thomas J.,Gottlieb Arlan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference35 articles.

1. Ifosfamide-pharmacology, safety and therapeutic potential

2. Pharmacology of acetaldehyde

3. (1971). Pharmacological studies with ifosfamide–a new oxazaphosphorine compound. Proceedings of the 7th International Congress of chemotherapy, Prague, 1971. In: Semonsky, M., Hejzler, M., Masak, S. eds. Advances in Antimicrobial and Antineoplastic Chemotherapy, Vol. 2, Baltimore: University Park Press, 749–756.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma;Leukemia & Lymphoma;2002-01

2. High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group;Leukemia & Lymphoma;2000-01

3. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma;Cancer;1996-06-01

4. Cytostatics and immunosuppressive drugs;Side Effects of Drugs Annual;1993